Skip to main content
logo
Bliss GVS Pharma Limited (NSE:BLISSGVS)
India flag India · Delayed Price · Currency is INR
236.50
+2.32 (0.99%)
Apr 6, 2026, 3:30 PM IST

Bliss GVS Pharma Revenue

Bliss GVS Pharma had revenue of 2.18B INR in the quarter ending December 31, 2025, with 3.72% growth. This brings the company's revenue in the last twelve months to 8.68B, up 7.19% year-over-year. In the fiscal year ending March 31, 2025, Bliss GVS Pharma had annual revenue of 8.10B with 5.13% growth.

Revenue (ttm)
8.68B
Revenue Growth
+7.19%
P/S Ratio
2.89
Revenue / Employee
8.99M
Employees
966
Market Cap
25.07B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20258.10B394.81M5.13%
Mar 31, 20247.70B186.57M2.48%
Mar 31, 20237.52B41.33M0.55%
Mar 31, 20227.47B1.70B29.50%
Mar 31, 20215.77B-1.12B-16.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Indoco Remedies17.60B
Innova Captab14.97B
Solara Active Pharma Sciences12.55B
Windlas Biotech8.68B
Orchid Pharma8.11B
RPG Life Sciences6.74B
Ind-Swift Laboratories5.94B
Beta Drugs3.85B
Revenue Rankings

Bliss GVS Pharma News

More News